Skin and soft tissue infections in injection drug users

Infectious Disease Clinics of North America

Volumn 16, Issue 3, 2002, Pages 697-712

  Ebright, John R ^a   Pieper, Barbara ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; CELLULITIS; DEBRIDEMENT; ENDOCARDITIS; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ABUSE; PATHOGENESIS; PYOMYOSITIS; REVIEW; RISK FACTOR; SKIN INFECTION; SKIN NECROSIS; SOFT TISSUE INFECTION; ULCER; WOUND CARE;

HUMANS; SKIN DISEASES; SOFT TISSUE INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 0036736644     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(02)00017-X     Document Type: Review

References (94)

1. Gibbs DH, Hamill DN, Magruder-Habib K. Populations at increased risk of HIV infection: current knowledge and limitations. J Acquir Immune Defic Syndr 1991;4:1-9.
2. Orangio GR, Pitlick SD, Della Latta P, et al. Soft tissue infection in parenteral drug abusers. Ann Surg 1984;199:97-100.
3. Organ DH. Surgical procedures upon the drug addict. Surgery, Gynecology and Obstetrics 1972;134:947-52.
4. Crane LR, Levine DP, Zervos MJ, et al. Bacteremia in narcotic addicts of the Detroit Medical Center: I. microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 1986;8:364-73.
5. Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 1986;8: 374-95.
6. Binswanger IA, Kral AH, Bluthenthal RN, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000; 30:579-81.
7. Centers for Disease Control and Prevention, Soft tissue infections among injection drug users-San Francisco, California, 1996-2000. MMWR Morb Mortal Wkly Rep 2001; 50(19):381-4.
8. Henriksen BM, Albrektsen SB, Simper LB, et al. Soft tissue infections from drug abuse, a clinical and microbiological review of 145 cases. Acta Orthop Scand 1994;65:625-8.
9. Schnall SB, Holtom PD, Lilley JC. Abscesses secondary to parenteral abuse of drugs. J Bone Joint Surg (Am) 1994;76:1526-30.
10. Bergstein JM, Baker IV EJ, Aprahamian C, et al. Soft tissue abscesses associated with parenteral drug abuse: presentation, microbiology, and treatment. Am Surg 1995;61:1105-8.
11. Summanen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft-tissue infections: comparison of injections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis 1995;20(Suppl 2):S279-82.
12. Murphy EL, Devita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis 2001;33:35-40.
13. Spijkerman IJ, vanAmeijden EJ, Mientjes GH, et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol 1996;49:1149-54.
14. Vlahov D, Sullivan M, Astembocski J, et al. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep 1992;5:595-8.
15. Creglar LL, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986;315: 1495-500.
16. Tierney BP, Stadelmann W. Necrotizing infection of the face secondary to intranasal impaction of "crack" cocaine. Ann Plast Surg 1999;43:640-3.
17. Wright CB, Lamoy RE, Hobson RW. Hemodynamic effects of intra-arterial injection of drugs of abuse. Surgery 1976;79:425-31.
18. Yeager RA, Hobson RW, Padberg FT, et al. Vascular complications related to drug abuse. J Trauma 1987;27:305-8.
19. Armstrong O, Fisher M. The treatment of Eikenella corrodens soft tissue infection in an injection drug user. W V Med J 1996;92:138-9.
20. Hoeger PH, Haupt G, Hoelzl E. Acute multifocal skin necrosis: synergism between invasive streptococcal infection and cocaine-induced tissue ischaemia? Acta Derm Venereol 1996; 76:239-41.
21. Centers for Disease Control. Community-acquired methicillin-resistant Staphylococcus aureus infections. Michigan. MMWR Morb Mortal Wkly Rep 1981;30:185-7.
22. Tuazon CU, Hill R, Sheagren JN. The microbiologic study of street heroin and injection paraphernalia. J Infect Dis 1974;129:327-9.
23. Bohlen LM, Muhlemann K, Dubuis O, et al. Outbreak among drug users caused by a clonal strain of group A streptococcus. Emerg Infect Dis 2000;6:175-9.
24. Makman MH. Morphine receptors in immunocytes and neurons. Adv Neuroimmunol 1994;4:69-82.
25. Risclahl JM, Khanna KV, Peterson PK, et al. Opiates and infection. J Neuroimmunol 1998;83:4-18.
26. Contoreggi C, Rexroad VE, Lange WR. Current management of infectious complications in the injecting drug user. J Subst Abuse Treat 1998; 15:95-106.
27. Ginsberg MB. Cellulitis: analysis of 101 cases and review of the literature. South Med J 1981;74:530-3.
28. Hemingway DM, Balfour AE. McCartney AC, et al. Streptococcus milleri complex groin abscess in intravenous drug abusers. Scott Med J 1992;37:116-7.
29. Myers EM, Kirkland LK, Mickey R. The head and neck sequelae of cervical intravenous drug abuse. Laryngoscope 1998;98:213-8.
30. Towers JD. The use of intravenous contrast in MRI of extremity infection. Semin Ultrasound CT MRI 1997;18:269-75.
31. Yiengpruksawan A, Ganepola AP, Freeman HP. Acute soft tissue infection in intravenous drug abusers: its differential diagnosis by ultrasonography. J Natl Med Assoc 1986;78:1193-6.
32. Simmen HP, Giovanoli P, Battaglia H, et al. Soft tissue infections of the upper extremities with special consideration of abscesses in parenteral drug abusers. J Hand Surg 1995;20B: 797-800.
33. Thomas III WO, Almand JD, Stark GB, et al. Hand injuries secondary to subcutaneous illicit drug injections. Ann Plast Surg 1995;34:27-31.
34. Webb D, Thadepalli H. Skin and soft tissue polymicrobial infections from intravenous abuse of drugs. West J Med 1979;130:200-4.
35. Lawlor MT, Crowe HM, Quintiliani R. Cellulitis due to Streptococcus pneumoniae: case report and review. Clin Infect Dis 1992;14:247-50.
36. Levine DP. Skin and soft tissue infections in intravenous drug abusers. In: Levine DP, Sobel JD, editors. Infections in intravenous drug abusers. 1st edition. New York (NY): Oxford University Press; 1991. p. 186, 190-1.
37. Whittiker DM. A fatal case of toxic shock associated with group A streptococcal cellulitis. J Am Board Fam Pract 1992;5:523-6.
38. Pieper B. A retrospective analysis of venous ulcer healing in current and former users of injected drugs. JWOCN 1996;23:291-6.
39. Wallace JR, Lucas CE, Ledgerwood CE. Social, economic, and surgical anatomy of a drug-related abscess. Am Surg 1986;52:398-401.
40. Petrie PW, Lamb DW. Severe hand problems in drug addicts following self administered injections. Hand 1973;5:130-4.
41. Hillstrom RP, Cohn AM, McCarroll KA. Vocal cord paralysis resulting from neck injections in the intravenous drug use population. Laryngoscope 1990;100:503-6.
42. Tom MB, Rice DH. Presentation and management of neck abscess: a retrospective analysis. Laryngoscope 1988;98:877-80.
43. Merhar GL, Colley DP, Clark RH. Cervicothoracic complications of intravenous drug abuse. Comput Tomogr 1981;5:271-82.
44. Callahan TE, Schecter WP, Horn JK. Necrotizing soft tissue injection masquerading as cutaneous abscess following illicit drug injection. Arch Surg 1998;133:812-8.
45. Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001;33:6-15.
46. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest 1996;110:219-29.
47. Rietveld JA, Pilmore HL, Jones PG, et al. Necrotizing fasciitis: a single center's experience. N Z Med J 1995;108:72-4.
48. Sudarsky LA, Laschinger JC, Coppa GF, et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 1987;206:661-5.
49. Webb HE, Hoover NW, Nichols DR, et al. Streptococcal gangrene. Arch Surg 1962;85: 969-73.
50. Chelsom J, Halstensen A, Haga T, et al. Necrotizing fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994;344:1111-5.
51. Bosshardt TL, Henderson VJ, Claude H, et al. Necrotizing soft-tissue infections. Arch Surg 1996;131:846-52.
52. Brogan TV, Nizet V. A clinical approach to differentiating necrotizing fasciitis from simple cellulitis. Infect Med 1997;14:734-8.
53. Diazgranados CA, Bisno AL. Clues to the early diagnosis of group A streptococcal necrotizing fasciitis. Infect Med 2001;18:198-206.
54. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997;90:1065-8.
55. Becker M, Zbaren P, Hermans R, et al. Necrotizing fasciitis: of the head and neck: role of CT in diagnosis and management. Radiology 1997;202:471-6.
56. Zittergruen M, Grose C. Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care 1993;9:26-8.
57. Falasca GF, Reginato AJ. The spectrum of myositis and rhabdomyolysis associated with bacterial infection. J Rheumatol 1994;21:1932-7.
58. Stevens D. Necrotizing fasciitis: don't wait to make a diagnosis. Infect Med 1997;9:684,688.
59. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting-drug users-Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000;49(24):543-5.
60. Greater Glasgow Health Board. Scottish Centre for Infection and Environmental Health, Djuretic T: Costridium noryi is likely cause of "serious unexplained illness" as cases continue to be reported. Eurosurveillance Weekly 2000;4(24):000615.
61. McGuigan C. A further outbreak of serious injection among injecting drug users in the west of Scotland. Eurosurveillance Weekly 2001;5(28):010712.
62. Centers for Disease Control and Prevention. Unexplained illness and death among injecting-drug users-Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000;49(22):489-92.
63. McGregor JA, Soper DE, Lovell G, et al. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989;161:987-95.
64. Centers for Disease Control. Wound botulism. California. MMWR Morb Mortal Wkly Rep 1995;44:889-92.
65. Kimura AC, Higa JI, Levin RM, et al, Necrotizing fasciitis and Clostridium sordellii among black tar heroin users [abstract 110]. In Program and Abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America, San Francisco: Infectious Diseases Society of America; 2001. p. 58.
66. Athwal B, Gale A. Wound botulism in an injecting drug user in England. Eurosurveillance Weekly 2000;4(20):000518.
67. Gruner E, Opravil M, Altwegg M, et al. Nontoxigenic Corynebacterium diphtheriae isolated from intravenous drug users. Clin Infect Dis 1994;18:94-6.
68. Ringertz SH, Hoiby EA, Jensenius M. Injectional anthrax in a heroin skin-popper. Lancet 2000;356:1574-5.
69. Centers for Disease Control and Prevention. Tetanus among injection-drug users-California, 1997. MMWR Morb Mortal Wkly Rep 1998;47:149-51.
70. Passaro DJ, Benson Werner S, McGee J. Wound botulism associated with black tar heroin among injection drug users. JAMA 1998;279:859-63.
71. Harbath SJ, Lew DP. Pyomyositis as a nontropical disease. In: Remington J, Swartz MN, editors. Current clinical topics in infectious diseases, vol 17. Malden, MA: Blackwell Science Publishers; 1997. p. 37-50.
72. Ashken MH, Cotton RE. Tropical skeletal muscle abscesses (pyomyositis tropicans). Br J Surg 1963;50:846-52.
73. Hossain A, Reis ED, Soundararajan K, et al. Nontropical pyomyositis: analysis of eight patients in an urban center. Am Surg 2000;66:1064-6.
74. Hsueh PR, Hsine TR, Hsieh WC. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin Infect Dis 1996;22:858-60.
75. Lo TS, Mooers MG, Wright LJ. Pyomyositis complicating acute bacterial endocarditis in an intravenous drug user. N Engl J Med 2000;342:1614-5.
76. Patel SR, Olenginski TP, Perruquet JL, et al. Pyomyositis: clinical features and pre-disposing conditions. J Rheumatol 1997;24:1734-8.
77. Santaella RO, Fishman EK, Lipsett PA. Primary vs secondary iliopsoas abscess. Arch Surg 1995;130:1309-13.
78. Fellner MJ, Weinstein LH. Cutaneous stigmata of drug addiction. Int J Dermatol 1979;18: 305-6.
79. Kirchenbaum SE, Midenberg ML. Pedal and lower extremity complications of substance abuse. Journal of the American Podiatry Association 1982;72:380-7.
80. Dow G, Browne A, Sibbald RG: Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy/Wound Management 1999;45(8):23-40.
81. Kunimoto BT. Assessment of venous leg ulcers: an in-depth discussion of a literature-guided approach. Ostomy/Wound Management 2001;47(5):38-53.
82. Kunimoto BT. Management and prevention of venous leg ulcers: a literature-guided approach Ostomy/Wound Management 2001;47(6):36-49.
83. Daly JM, Reynolds J, Sigal RK, et al. Effect of dietary protein and amino acids on immune function. Crit Care Med 1990;18(Suppl 2):S86-S96.
84. Schroeder D, Gillanders L, Mahr K, et al. Effects of immediate postoperative enteral nutrition on body composition, muscle function, and wound healing. J Parenter Enteral Nutr 1991;15:376-83.
85. Pieper B, Rossi R, Templin T. Pain associated with venous ulcers in injecting drug users. Ostomy/Wound Management 1998;44(11):54-67.
86. Falabella AF. Debridement and management of exudative wounds. Dermatologic Therapy 1999;9:36-43.
87. Fowler E, Rijswijk L. Using wound debridement to help achieve goals of care. Ostomy/ Wound Management 1995;9:69-77.
88. Bergan JJ, Sparks SR. Non-elastic compression: an alternative in management of chronic venous insufficiency. J WOCN 2000;27:83-9.
89. Cordts PR, Hanrahan LM, Rodriquez AA, et al. A prospective randomized trial of Unna's boot versus Duoderm CGF hydroactive dressing plus compression in the management of venous leg ulcers. J Vasc Surg 1992;15:480-6.
90. Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous ulcers. A randomized clinical trial. J Am Acad Dermatol 1986;15:186-91.
91. O'Meara SM, Cullum NA, Majid M, et al. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001;88:4-21.
92. Thomson P, Taddonio T, Tait M, et al. Correlation between swab and biopsy for the quantification of burn wound microflora. Proceedings of the International Congress of Burn Injury 1990;8:381.
93. Robson M, Heggers J. Surgical infection II: the beta-hemolytic streptococcus. J Surg Res 1969;9:289-92.
94. Dolynchuk K, Hull P, Guenther L, et al. The role of Apligraf™ in the treatment of venous leg ulcers. Ostomy/Wound Management 1999;45(1):34-43.